miR-32 functions as a tumor suppressor and directly targets SOX9 in human non–small cell lung cancer [Retraction]
Authors Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, Yu L
Received 7 October 2016
Accepted for publication 7 October 2016
Published 20 October 2016 Volume 2016:9 Pages 6379—6380
The Editor-in-Chief and Publisher of OncoTargets and Therapy have been alerted to unacceptable levels of duplication with another published paper: Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J and Yu L. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients. Diagnostic Pathology. 9;198:2014.
Accordingly, we retract Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, Yu L. miR-32 functions as a tumor suppressor and directly targets SOX9 in human non–small cell lung cancer. OncoTargets and Therapy. 2015;8:1773–1783.
This Retraction relates to
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]